𝔖 Bobbio Scriptorium
✦   LIBER   ✦

163 Variants in Interferon-α Pathway Genes and Response to Treatment of Chronic Hepatitis C

✍ Scribed by O'Brien, Thomas R.; Welzel, Tania M.; Bonkovsky, Herbert L.; Chung, Raymond T.; Naishadham, Deepa; Wright, Elizabeth C.; Chanock, Stephen; Morgan, Timothy R.

Book ID
123084643
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
119 KB
Volume
134
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Variants in interferon-alpha pathway gen
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial
✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Tumor necrosis factor α gene expression
Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C
✍ E Larrea; N Garcia; C Qian; M P Civeira; J Prieto 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

Tumor necrosis factor a (TNF-a) is a cytokine with infectious agents and has been shown to exert direct pleiotropic properties that is induced in a variety of antiviral effects. [3][4][5] Although low levels of TNF-a can pathological situations including viral infections. In this contribute to cell